Swiss Biotech Stock News

In July 2026, European markets have shown resilience, with the pan-European STOXX Europe 600 Index rising by nearly 2% amid easing inflation concerns and stable unemployment rates. As investors navigate these conditions, growth companies with high insider ownership can present compelling opportunities due to their potential alignment of management interests with shareholders and the ability to capitalize on favorable economic developments.

As the pan-European STOXX Europe 600 Index recently advanced by 1.96%, bolstered by lower oil prices and easing inflation expectations, investor sentiment in Europe appears cautiously optimistic. In this environment, identifying undervalued stocks becomes crucial, as these opportunities may offer potential for growth when market conditions stabilize further.

Client win puts Bachem Holding in focus ImmuPharma PLC has appointed Bachem Holding (SWX:BANB) subsidiary Bachem AG to manufacture the active pharmaceutical ingredient for its Kapiglucagon program, marking a key Chemistry, Manufacturing and Controls milestone for the project. The collaboration positions Bachem Holding within the next stage of Kapiglucagon development, with work initially centered on the active ingredient before ImmuPharma selects a separate partner for drug product...

SGS (SWX:SGSN) has launched SGS Compass, a cloud and AI driven platform aimed at tightening supplier risk management, compliance and sustainability across complex global supply chains for corporate and institutional clients. See our latest analysis for SGS. The launch of SGS Compass comes as SGS shares trade at CHF95.30, with a 30 day share price return of 6.53% and a 90 day share price return of 15.35%. The 1 year total shareholder return of 19.12% contrasts with a 5 year total shareholder...

Vietnam’s latest crackdown on counterfeit luxury goods is reshaping the risk and opportunity mix for global luxury brands. With stricter enforcement on fake handbags, shoes, and accessories, some listed companies exposed to this news may see cleaner channels, changing price power, and potential shifts in supply chain costs. This article looks at three stocks from our Global Luxury Brands screener that appear positively exposed to these developments. It is intended to help you think through...

Sulzer (SWX:SUN) has drawn fresh attention after agreeing to supply a new chemical recycling facility for end of life plastics to Vitol’s Western Polymer Unit, highlighting its environmental technology offering. See our latest analysis for Sulzer. The recycling facility agreement comes after a choppy period for Sulzer’s stock, with the share price up 2.29% on the day to CHF138.4 but down 11.62% over 30 days and 17.03% over 90 days. The 3-year total shareholder return of 91.34% and 5-year...

In recent weeks, the European market has shown resilience, with the pan-European STOXX Europe 600 Index rising by nearly 2% amid easing inflation concerns and unexpected growth in German retail sales. As investors navigate these evolving conditions, stocks characterized by strong insider ownership often stand out as they can signal confidence from those closest to the company’s operations and strategic direction.

The European Court of Justice’s decision to confirm Google’s €4.1b antitrust fine has put fresh attention on how regulators treat large digital platforms, and by extension, on the opportunities and risks for European tech stocks that operate alongside them. For investors, this ruling may reshape how power and profit are shared across search, mobile and app ecosystems. This article looks at 3 European technology stocks from our screener that appear closely exposed to this legal shift, helping...

Sirma Group Holding JSC’s move to become a Temenos (SWX:TEMN) Referral Partner, focusing on Bulgaria and Albania, puts fresh attention on how this banking software company is building its regional reach through alliances. See our latest analysis for Temenos. Temenos shares trade at CHF69.0 after a 1 day share price return of 4.39% and a 7 day share price return of 5.10%. However, the share price is down 15.34% year to date, while the 1 year total shareholder return of 21.87% points to a...

Partners Group has recently launched its B Residences strategy, committing about US$220,000,000 to develop a c. 70‑story Breitling‑branded luxury condominium tower in Miami’s Brickell district, while also investing US$250,000,000 as sole lead investor in an Avenue Capital aviation leasing continuation vehicle. Together, these moves highlight Partners Group’s push into branded residential real estate and aviation leasing, broadening its private‑markets offering across lifestyle property and...

As the pan-European STOXX Europe 600 Index remains relatively stable, investors are navigating a landscape marked by easing inflation expectations and mixed PMI data across the eurozone. In this context, dividend stocks can offer a reliable income stream, making them an appealing choice for those looking to balance growth with stability in their portfolios.

Miami luxury tower project puts Partners Group Holding in focus Partners Group Holding (SWX:PGHN) is drawing fresh attention after Partners Group AG announced its B Residences strategy, a Breitling branded luxury condominium tower in Miami’s Brickell neighborhood, with an intended investment of about US$220 million. See our latest analysis for Partners Group Holding. For investors, the B Residences announcement arrives after a challenging stretch, with Partners Group Holding’s share price...

Interroll Holding AG ( VTX:INRN ), is not the largest company out there, but it received a lot of attention from a...

It looks like Züblin Immobilien Holding AG ( VTX:ZUBN ) is about to go ex-dividend in the next 4 days. The ex-dividend...

How Novartis Stock Has Been Performing Novartis (SWX:NOVN) has delivered a 34.9% total return over the past year, with the stock last closing at CHF 124.34. Year to date, the total return stands at 14.6%, supported by reported annual revenue of $56,578.0m and net income of $13,534.0m. In the shorter term, Novartis has logged gains of 0.7% over the past day, about 2.8% over the past week, and around 4.1% over both the past month and the past 3 months. These figures provide a snapshot of how...

Compagnie Financière Richemont SA ( VTX:CFR ) led the SWX gainers with a relatively large price hike in the past couple...

Earlier in 2026, SGS announced it had been reappointed for the third time by the Gabonese government to deliver pre-export verification of conformity services, extending a partnership that has spanned around a decade and supports consumer protection, trade security, and product compliance. This renewed mandate reinforces SGS’s role as a trusted compliance partner for national authorities, highlighting how long-running government programs can underpin the group’s inspection and certification...

As European markets show mixed macroeconomic data and a modest rise in major indexes, investors are increasingly looking for opportunities in stocks that may be undervalued relative to their intrinsic value. In such an environment, identifying companies with strong fundamentals and stable financials can provide potential avenues for growth as the market seeks stability amid economic fluctuations.

Sandoz Group AG has opened a fully digitally integrated, US$99 million biosimilar development centre in Ljubljana, Slovenia, spanning about 10,000 m² and employing more than 200 scientists as part of its plan to build an end-to-end European biosimilar hub. The facility’s integration with sites in Germany, the UK, Slovenia and the recently acquired Toulouse, France, biosimilar plant highlights Sandoz’s push to bring more biosimilar development and manufacturing in-house across its European...

Idorsia (SWX:IDIA) has agreed to a senior secured term loan of up to CHF 250 million with funds managed by Pharmakon Advisors, refinancing its existing New Money Facility and removing near term debt maturities. See our latest analysis for Idorsia. Idorsia's debt refinancing news lands after a sharp shift in sentiment, with the 90 day share price return of 84.34% and 1 year total shareholder return of 208.23% contrasting with weaker 3 and 5 year total shareholder returns. This suggests...

PolyPeptide Group (SWX:PPGN) has attracted fresh attention after swinging from a net loss to a net profit in its latest quarter, a shift that coincides with supportive analyst sentiment. See our latest analysis for PolyPeptide Group. The recent swing to profit appears to have coincided with a sharp improvement in sentiment, with PolyPeptide Group’s share price at CHF39.35 delivering a 59.96% 90 day share price return and a 98.14% 1 year total shareholder return, even though the 5 year total...

Zug Estates Holding AG recently completed the placement of a CHF 100,000,000 seven-year green bond with a 1.35% fixed coupon, intending to list it on the SIX Swiss Exchange and use the proceeds to refinance projects under its Green Finance Framework. This transaction expands Zug Estates’ sustainable financing base and highlights ongoing investor appetite for real estate issuers that align funding with transparent environmental criteria. We’ll now examine how this green bond issuance, and its...

Siegfried Holding (SWX:SFZN) has opened a new large scale API manufacturing facility in Minden, Germany, adding 100 m³ of reactor capacity and expanding its role as a global CDMO for small molecule drug substances. See our latest analysis for Siegfried Holding. Despite Siegfried Holding’s new API facility pointing to expanded capacity and customer demand, recent momentum has been weak, with the share price down 16.82% over 30 days and the 1 year total shareholder return down 28.36%,...

Sandoz Group (SWX:SDZ) has opened a new biosimilar development centre in Ljubljana, Slovenia, a fully digitally integrated US$99 million facility that expands its in house capabilities across drug substance and drug product development. See our latest analysis for Sandoz Group. Set against this investment in Ljubljana, Sandoz Group’s 1 day share price return declined 1.60% to CHF67.68, while its year to date share price return of 18.28% and 1 year total shareholder return of 57.12% suggest...